TITLE

Longitudinal Analysis of Serological Responses of Adults to Helicobacter pylori Antigens

AUTHOR(S)
Perez-Perez, Guillermo I.; Maw, Anna M.; Feingold-Link, Lani; Gunn, Jennifer; Bowers, Andrea L.; Minano, Cecilia; Rautelin, Hilpi; Kosunen, Timo U.; Blaser, Martin J.
PUB. DATE
September 2010
SOURCE
Journal of Infectious Diseases;9/15/2010, Vol. 202 Issue 6, p916
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Because Helicobacter pylori persist for decades in the human stomach, the aim of this study was to examine the long-term course of H. pylori-specific serum immunoglobulin G (IgG) responses with respect to subclass and antigenic target. We studied paired serum samples obtained in 1973 and in 1994 in Vammala, Finland, from 64 healthy H. pylori-positive adults and from other healthy control subjects. H. pylori serum immunoglobulin A, IgG, and IgG subclass responses were determined by antigen-specific enzyme-linked immunosorbent assays. H. pylori-specific IgG1 and IgG4 subtype responses from 47 subjects were similar in 1973 and 1994, but not when compared with unrelated persons. H. pylori-specific IgG1:IgG4 ratios among the participants varied >1000-fold; however, 57 (89.1%) of 64 subjects had an IgG1:IgG4 ratio >1.0, consistent with a predominant IgG1 (Th1) response. Furthermore, ratios in individual hosts were stable over the 21-year period (r = 0.56; P < .001). The immune response to heat shock protein HspA was unchanged in 49 (77%) of the 64 subjects tested; of the 15 whose serostatus changed, all seroconverted and were significantly younger than those whose status did not change. These findings indicate that H. pylori-specific antibody responses are host-specific with IgG1:IgG4 ratios stable over 21 years, IgG1 responses predominating, and HspA seroconversion with aging.
ACCESSION #
54295032

 

Related Articles

  • Whole-blood tests for detecting Helicobacter pylori.  // Modern Medicine;Sep96, Vol. 64 Issue 9, p26 

    Reports on the approval of two new whole-blood tests for the detection of IgG antibodies to Helicobacter pylori. Test as a complement to the FlexSure HP serum-based test for H pylori; Description on how the test is conducted.

  • Don't be too quick to treat H pylori; wait for ulcer recurrence.  // Modern Medicine;Feb94, Vol. 62 Issue 2, p15 

    Recommends a technique for treating Helicobacter pylori. Triple treatment with bismuth subsalicylate, metronidazole and tetracyline.

  • H pylori rarely recurs following successful triple therapy.  // Geriatrics;Jan94, Vol. 49 Issue 1, p60 

    Rports on a prospective study which showed that the rate of `Helicobacter pylori' reinfection of the Gastro-Intestinal (GI) tract is low after successful treatment with standard triple therapy.

  • Absence of dyspeptic symptoms as a test for Helicobacter pylori eradication. Phull, Perminder S.; Halliday, David // BMJ: British Medical Journal (International Edition);2/10/96, Vol. 312 Issue 7027, p349 

    Examines the absence of dyspeptic symptoms as a test for Helicobacter pylori eradication. Changes in the course of duodenal ulcer disease; Need for endoscopy.

  • Helicobacter pylori: Review of triple, dual, 7-day, and other treatment strategies. Fennerty, M. Brian; Melnyk, Clifford S. // Formulary;Nov95, Vol. 30 Issue 11, p682 

    Examines the effectiveness of triple, dual, 7-day and other treatment strategies against Helicobacter pylori. History of the pathogen's first identification and isolation; Tests for establishing Helicobacter pylori infection; Components of standard triple therapy.

  • Omeprazole plus amoxicillin knocks out H pylori ulcer disease.  // Geriatrics;Sep93, Vol. 48 Issue 9, p94 

    Presents an abstract of the article entitled `Omeprazole Plus Amoxicillin: Efficacy of Various Treatment Regiments to Eradicate Helicobacter Pylori,' by J Labenz, E Gyenes, GH Ruhl. et al. published in the 1993 issue of the `Am J Gastroenterol' periodical.

  • H pylori: Expert panel updates NIH guidelines on testing and treating.  // Modern Medicine;Jul97, Vol. 65 Issue 7, p33 

    Reports on the effectiveness of treatment regimens for Helicobacter pylori that were approved by the US Food and Drug Administration (FDA). Opinion of a panel of expert gastroenterologists who issued a consensus report on Helicobacter pylori; Initial testing; Post-treatment testing. INSET: A...

  • News & views. Hinchey, Kevin T. // Cortlandt Forum;10/25/97, Vol. 10 Issue 10, p37 

    Presents an abstract and comment on the study `Undertreatment of Helicobacter pylori infection Among Medicare Patients,' by J. Roll, A. Weng et al and published in a 1997 issue of the `Archives of Internal Medicine' journal.

  • Helicobacter gastroduodenitis: A serious infectious disease. Axon, Anthony; Forman, David // BMJ: British Medical Journal (International Edition);05/17/97, Vol. 314 Issue 7092, p1430 

    Editorial. Focuses on physicians' reluctance to treat Helicobacter pylori infection. Treatment regimens for Helicobacter pylori infection; Efforts to determine the best management of patients.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics